Susquehanna International Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Susquehanna International Group’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,001	Closed	-$11.6K	–	13686
2023 Q1	$11.6K	Buy	+20,001	New	+$15.9K	﹤0.01%	12179
2022 Q4	–	Sell	-2,529	Closed	-$7K	–	14252
2022 Q3	$7K	Buy	+2,529	New	+$9.55K	﹤0.01%	12849
2022 Q1	–	Sell	-4,580	Closed	-$31K	–	14348
2021 Q4	$31K	Buy	+4,580	New	+$46.9K	﹤0.01%	12740
2019 Q1	–	Sell	-184	Closed	-$7K	–	10133
2018 Q4	$7K	Buy	+184	New	+$15.5K	﹤0.01%	8770
2017 Q2	–	Sell	-76	Closed	-$44.4K	–	10021
2017 Q1	$47K	Buy	+76	New	+$27K	﹤0.01%	8612
2014 Q2	–	Sell	-80	Closed	-$180K	–	10201
2014 Q1	$180K	Buy	+80	New	+$205K	﹤0.01%	8309

Other funds holding VYNT

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group's VYNT Position: Q2 2023 in Review

Susquehanna International Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 20,001 shares — an estimated $11.6K sold.

Susquehanna International Group first reported a position in VYNT in Q1 2014 and held it in 6 quarters. The position peaked at $180K in Q1 2014. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.

Susquehanna International Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 20,001 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $11.6K.
Susquehanna International Group first reported a position in Vyant Bio, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
Susquehanna International Group's Vyant Bio, Inc. Common Stock position peaked at $180K in Q1 2014.
1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.